Correspondence COVID-19: Melatonin as a potential adjuvant treatment.
作者信息
Salles Cristina
机构信息
Bahiana's School of Medicine and Public Health, Salvador, Brazil.
出版信息
Life Sci. 2020 Jul 15;253:117716. doi: 10.1016/j.lfs.2020.117716. Epub 2020 Apr 22.
Abstract
摘要
相似文献
1
Correspondence COVID-19: Melatonin as a potential adjuvant treatment.通信：新型冠状病毒肺炎（COVID-19）：褪黑素作为一种潜在的辅助治疗方法
Life Sci. 2020 Jul 15;253:117716. doi: 10.1016/j.lfs.2020.117716. Epub 2020 Apr 22.
2
Delirium, sleep, COVID-19 and melatonin.谵妄、睡眠、新冠病毒与褪黑素
Sleep Med. 2020 Nov;75:542. doi: 10.1016/j.sleep.2020.05.028. Epub 2020 May 27.
3
Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?褪黑素缺乏是新冠病毒肺炎高危患者的共同发病机制吗？
Life Sci. 2020 Sep 1;256:117902. doi: 10.1016/j.lfs.2020.117902. Epub 2020 Jun 3.
4
Reply to 'Delirium, sleep, COVID-19 and melatonin'.对《谵妄、睡眠、新冠病毒病与褪黑素》的回复
Sleep Med. 2020 Nov;75:543. doi: 10.1016/j.sleep.2020.05.027. Epub 2020 May 25.
5
Melatonin as a putative protection against myocardial injury in COVID-19 infection.褪黑素作为一种可能预防新型冠状病毒肺炎感染所致心肌损伤的物质。
Expert Rev Clin Pharmacol. 2020 Sep;13(9):921-924. doi: 10.1080/17512433.2020.1814141. Epub 2020 Sep 7.
6
Delirium and sleep disturbances in COVID-19: a possible role for melatonin in hospitalized patients?新型冠状病毒肺炎中的谵妄与睡眠障碍：褪黑素在住院患者中可能发挥的作用？
Sleep Med. 2020 Jun;70:111. doi: 10.1016/j.sleep.2020.04.006. Epub 2020 Apr 17.
7
Response to COVID-19 phenotyping correspondence.针对 COVID-19 表型相关信件的回复。
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.02756-2020. Print 2020 Aug.
8
Comment on Melatonin as a potential adjuvant treatment for COVID-19.关于褪黑素作为新冠病毒病潜在辅助治疗方法的评论。
Life Sci. 2020 Jul 15;253:117739. doi: 10.1016/j.lfs.2020.117739. Epub 2020 Apr 30.
9
Prevention and Control of COVID-19 in Chronic Kidney Disease: Correspondence.慢性肾脏病中新冠病毒病的预防与控制：通信
Indian J Pediatr. 2020 Nov;87(11):968-969. doi: 10.1007/s12098-020-03398-6. Epub 2020 Jul 7.
10
BCG Vaccination Policy and Protection Against COVID-19: Correspondence.卡介苗接种政策与新冠病毒防护：通信
Indian J Pediatr. 2020 Sep;87(9):772-773. doi: 10.1007/s12098-020-03462-1. Epub 2020 Aug 11.
引用本文的文献
1
Is there a link between COVID-19 and obstructive sleep apnea?2019冠状病毒病与阻塞性睡眠呼吸暂停之间存在关联吗？
Sleep Sci. 2021 Jul-Sep;14(3):299-302. doi: 10.5935/1984-0063.20200078.
2
Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence.利用图神经网络和协调多种证据进行 COVID-19 的药物再利用。
Sci Rep. 2021 Nov 30;11(1):23179. doi: 10.1038/s41598-021-02353-5.
3
Melatonin for the Early Treatment of COVID-19: A Narrative Review of Current Evidence and Possible Efficacy.褪黑素治疗 COVID-19 的早期应用：对现有证据和可能疗效的叙述性综述。
Endocr Pract. 2021 Aug;27(8):850-855. doi: 10.1016/j.eprac.2021.06.001. Epub 2021 Jun 10.
4
Drug Repurposing for COVID-19 using Graph Neural Network with Genetic, Mechanistic, and Epidemiological Validation.使用具有遗传、机制和流行病学验证的图神经网络对新冠病毒进行药物再利用研究
Res Sq. 2020 Dec 11:rs.3.rs-114758. doi: 10.21203/rs.3.rs-114758/v1.
5
Familiar Dermatologic Drugs as Therapies for COVID-19.常见皮肤科药物在 COVID-19 治疗中的应用。
Actas Dermosifiliogr (Engl Ed). 2021 Feb;112(2):118-126. doi: 10.1016/j.ad.2020.09.004. Epub 2020 Oct 10.
6
Mitochondria at the Crossroads of Physiology and Pathology.处于生理与病理交叉点的线粒体
J Clin Med. 2020 Jun 24;9(6):1971. doi: 10.3390/jcm9061971.
本文引用的文献
1
COVID-19: Melatonin as a potential adjuvant treatment.新型冠状病毒肺炎：褪黑素作为一种潜在的辅助治疗方法。
Life Sci. 2020 Jun 1;250:117583. doi: 10.1016/j.lfs.2020.117583. Epub 2020 Mar 23.
2
Sleep deprivation predisposes allergic mice to neutrophilic lung inflammation.睡眠剥夺使过敏性小鼠易患嗜中性粒细胞性肺炎症。
J Allergy Clin Immunol. 2018 Mar;141(3):1018-1027.e4. doi: 10.1016/j.jaci.2017.06.025. Epub 2017 Jul 19.
Zotero 插件